βIII-Tubulin Suppression Enhances the Activity of Amuvatinib To Inhibit Cell Proliferation in C-Met Positive Non-Small Cell Lung Cancer Cells

Researchers showed that activity of the multi-kinase inhibitor Amuvatinib was enhanced by βIII-tubulin suppression in independent NSCLC cell lines.